These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 25519785)

  • 21. Asthma masquerading as chronic obstructive pulmonary disease: a study of smokers fulfilling the GOLD definition of chronic obstructive pulmonary disease.
    Al-Kassimi FA; Abba AA; Al-Hajjaj MS; Alhamad EH; Raddaoui E; Shaikh SA
    Respiration; 2011; 82(1):19-27. PubMed ID: 21282939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment implications on morbidity and mortality in COPD.
    Mapel DW
    Chest; 2004 Aug; 126(2 Suppl):150S-158S; discussion 159S-161S. PubMed ID: 15302775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic respiratory diseases at primary health care level in Georgia: the results of the pilot study.
    Chkhaidze I; Maglakelidze T; Khaltaev N
    Monaldi Arch Chest Dis; 2009 Dec; 71(4):141-6. PubMed ID: 20440917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Asthma and COPD: definitions, epidemiology, and treatment guidelines.
    Berger WE; Cline DC
    Postgrad Med; 2005 Dec; 118(6 Suppl Acute):2-8. PubMed ID: 19667710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The global epidemiology and burden of opioid dependence: results from the global burden of disease 2010 study.
    Degenhardt L; Charlson F; Mathers B; Hall WD; Flaxman AD; Johns N; Vos T
    Addiction; 2014 Aug; 109(8):1320-33. PubMed ID: 24661272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Smoking prevalence and cessation characteristics among U.S. adults with and without COPD: findings from the 2011 Behavioral Risk Factor Surveillance System.
    Schauer GL; Wheaton AG; Malarcher AM; Croft JB
    COPD; 2014 Dec; 11(6):697-704. PubMed ID: 24841392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Profiles of chronic obstructive lung disease: characteristics of stable chronic obstructive lung disease in different parts of Asia.
    Bhome AB; Brashier B
    Curr Opin Pulm Med; 2014 Mar; 20(2):165-72. PubMed ID: 24419588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trends in chronic obstructive pulmonary disease in the Asia-Pacific regions.
    Tan WC
    Curr Opin Pulm Med; 2011 Mar; 17(2):56-61. PubMed ID: 21178626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distribution of COPD-related symptoms in the Middle East and North Africa: results of the BREATHE study.
    Tageldin MA; Nafti S; Khan JA; Nejjari C; Beji M; Mahboub B; Obeidat NM; Uzaslan E; Sayiner A; Wali S; Rashid N; El Hasnaoui A;
    Respir Med; 2012 Dec; 106 Suppl 2():S25-32. PubMed ID: 23290701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of smoking on airflow limitation in subjects with history of asthma and inactive tuberculosis.
    Kim HJ; Baek S; Kim HJ; Lee JS; Oh YM; Lee SD; Lee SW
    PLoS One; 2015; 10(4):e0125020. PubMed ID: 25915938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhaled corticosteroids and mortality in COPD.
    Macie C; Wooldrage K; Manfreda J; Anthonisen NR
    Chest; 2006 Sep; 130(3):640-6. PubMed ID: 16963657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Geographic distribution of chronic obstructive pulmonary disease prevalence in Africa, Asia and Australasia.
    Blanco I; Diego I; Bueno P; Fernández E; Casas-Maldonado F; Esquinas C; Soriano JB; Miravitlles M
    Int J Tuberc Lung Dis; 2019 Oct; 23(10):1100-1106. PubMed ID: 31627775
    [No Abstract]   [Full Text] [Related]  

  • 33. Asthma is not a common cause of severe chronic respiratory failure in non-smokers: ALOT study.
    Caramori G; Fabbri M; Paioli D; Falcone F; Severino C; Felisatti G; Arar O; Adcock IM; Fan Chung K; Barnes PJ; Ciaccia A; Papi A
    Monaldi Arch Chest Dis; 2005 Jun; 63(2):84-7. PubMed ID: 16128222
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Global perspective on tobacco control. Part I. The global state of the tobacco epidemic.
    Slama K
    Int J Tuberc Lung Dis; 2008 Jan; 12(1):3-7. PubMed ID: 18173869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Asthma, atopy and COPD in sub-Saharan countries: the challenges.
    Musafiri S; Joos G; Van Meerbeeck JP
    East Afr J Public Health; 2011 Jun; 8(2):161-3. PubMed ID: 22066305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic respiratory disease, inhaled corticosteroids and risk of non-tuberculous mycobacteriosis.
    Andréjak C; Nielsen R; Thomsen VØ; Duhaut P; Sørensen HT; Thomsen RW
    Thorax; 2013 Mar; 68(3):256-62. PubMed ID: 22781123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Epidemiologic aspects of respiratory aging: contribution of the PAQUID survey].
    Nejjari C; Tessier JF; Baldi I; Barberger-Gateau P; Dartigues JF; Salamon R
    Rev Epidemiol Sante Publique; 1997 Oct; 45(5):417-28. PubMed ID: 9446147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Burden and clinical features of chronic obstructive pulmonary disease (COPD).
    Pauwels RA; Rabe KF
    Lancet; 2004 Aug 14-20; 364(9434):613-20. PubMed ID: 15313363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of psychological status in patients with asthma and COPD.
    Asnaashari AM; Talaei A; Haghigh B
    Iran J Allergy Asthma Immunol; 2012 Mar; 11(1):65-71. PubMed ID: 22427478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Costs of illness for asthma and COPD in adults in Germany].
    Kirsch F; Teuner CM; Menn P; Leidl R
    Gesundheitswesen; 2013 Jul; 75(7):413-23. PubMed ID: 23553190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.